Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of renal injury after open heart surgery
IRCT20190506043492N3Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine in acute kidney failure (AKF) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Serum creatinine after open heart surgery, Blood urea nitrogen after open heart surgery and 2 more. Started Apr 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20190506043492N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043492N3.